HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, Martin JN, Krone MR, Deeks SG, Norris PJ, NIAID Center for HIV/AIDS Vaccine Immunology. AIDS. 2010 May 15; 24(8):1095-105.